RE:DEAThanks for sharing Danno13. I found the second blue highlighted section humorous...if they only knew....or in the case of some politicians, had a clue.
“The scope of and demand for FDA oversight for medical marijuana and related products may grow considerably. In the short term, FDA may need to generate or update a substantial amount of technical information to clarify its regulatory approach to marijuana for relevant stakeholders. Given that marijuana is a complex substance containing various pharmaceutical components and is available to consumers in numerous formats, FDA may also need to consider long-term resource allocation to ensure that marijuana products consistently meet applicable regulatory standards.”
Meanwhile, a GOP congressman who does support legalization recently expressed concern that simply moving marijuana to Schedule III may inadvertently lead the pharmaceutical industry to overtake the cannabis industry.